153 related articles for article (PubMed ID: 36618070)
41. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
42. Does Failure to Achieve Pathologic Complete Response with Neoadjuvant Chemotherapy Identify Node-Negative Patients Who Would Benefit from Postmastectomy Radiation or Regional Nodal Irradiation?
Crown A; Gonen M; Le T; Morrow M
Ann Surg Oncol; 2021 Mar; 28(3):1328-1335. PubMed ID: 32959140
[TBL] [Abstract][Full Text] [Related]
43. Entire Versus Medial Supraclavicular Nodal Irradiation for Patients With High-Risk Node-Positive Breast Cancer.
Zhang L; Liu J; Ma J; Mei X; Chen X; Mo M; Wang X; Meng J; Shi W; Bazan JG; Shao Z; Zhang Z; Yu X; Guo X; Yang Z
Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):120-129. PubMed ID: 35654307
[TBL] [Abstract][Full Text] [Related]
44. Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score adjustment method.
Wang L; He Y; Li J; Wang T; Xie Y; Fan Z; Ouyang T
Breast Cancer Res Treat; 2020 Oct; 183(3):717-728. PubMed ID: 32715444
[TBL] [Abstract][Full Text] [Related]
45. Improved Survival after Breast-Conserving Therapy Compared with Mastectomy in Stage I-IIA Breast Cancer.
Ratosa I; Plavc G; Pislar N; Zagar T; Perhavec A; Franco P
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439197
[TBL] [Abstract][Full Text] [Related]
46. The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy.
Vicini FA; Horwitz EM; Lacerna MD; Brown DM; White J; Dmuchowski CF; Kini VR; Martinez A
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1069-76. PubMed ID: 9392546
[TBL] [Abstract][Full Text] [Related]
47. Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases.
Wu SP; Tam M; Shaikh F; Lee A; Chun J; Schnabel F; Guth A; Adams S; Schreiber D; Oh C; Gerber NK
Ann Surg Oncol; 2018 Sep; 25(9):2620-2631. PubMed ID: 29987606
[TBL] [Abstract][Full Text] [Related]
48. Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons.
Bradley JA; Dagan R; Ho MW; Rutenberg M; Morris CG; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):411-421. PubMed ID: 26611875
[TBL] [Abstract][Full Text] [Related]
49. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456
[TBL] [Abstract][Full Text] [Related]
50. Brachytherapy-based Accelerated Partial Breast Irradiation Provides Equivalent 10-Year Outcomes to Whole Breast Irradiation: A Matched-Pair Analysis.
Wobb JL; Shah C; Chen PY; Wallace M; Ye H; Jawad MS; Grills IS
Am J Clin Oncol; 2016 Oct; 39(5):468-72. PubMed ID: 25822231
[TBL] [Abstract][Full Text] [Related]
51. Clinical outcome of isolated locoregional recurrence in patients with breast cancer according to their primary local treatment.
Shenouda MN; Sadek BT; Goldberg SI; Keruakous AR; Croft BJ; Abi Raad RF; Taghian AG
Clin Breast Cancer; 2014 Jun; 14(3):198-204. PubMed ID: 24485702
[TBL] [Abstract][Full Text] [Related]
52. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
[TBL] [Abstract][Full Text] [Related]
53. Breast cancer outcomes following immediate breast reconstruction with implants versus autologous flaps: a propensity score-matched study.
Wu ZY; Han J; Kim HJ; Lee JW; Chung IY; Kim J; Lee SB; Son BH; Han HH; Eom JS; Jeong JH; Gong G; Kim HH; Ahn SH; Ko B
Breast Cancer Res Treat; 2022 Jan; 191(2):365-373. PubMed ID: 34755242
[TBL] [Abstract][Full Text] [Related]
54. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
[TBL] [Abstract][Full Text] [Related]
55. Long-term Oncologic Outcomes of Immediate Breast Reconstruction vs Conventional Mastectomy Alone for Breast Cancer in the Setting of Neoadjuvant Chemotherapy.
Wu ZY; Kim HJ; Lee JW; Chung IY; Kim JS; Lee SB; Son BH; Eom JS; Kim SB; Jung KH; Gong G; Kim HH; Ahn SH; Ko B
JAMA Surg; 2020 Dec; 155(12):1142-1150. PubMed ID: 33052412
[TBL] [Abstract][Full Text] [Related]
56. Breast-conserving therapy is associated with better survival than mastectomy in Early-stage breast cancer: A propensity score analysis.
Ji J; Yuan S; He J; Liu H; Yang L; He X
Cancer Med; 2022 Apr; 11(7):1646-1658. PubMed ID: 35212160
[TBL] [Abstract][Full Text] [Related]
57. Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
[TBL] [Abstract][Full Text] [Related]
58. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
[TBL] [Abstract][Full Text] [Related]
59. Effect of Breast Conservation Therapy vs Mastectomy on Overall Survival and Breast Cancer-Specific Survival Among Men With Stage I-II Breast Cancer: Analysis of SEER, 2000-2018.
He Y; Gao X; Wu J; Li X; Ma Z
Clin Breast Cancer; 2022 Jul; 22(5):410-417. PubMed ID: 35473920
[TBL] [Abstract][Full Text] [Related]
60. Different statistical techniques dealing with confounding in observational research: measuring the effect of breast-conserving therapy and mastectomy on survival.
van Maaren MC; le Cessie S; Strobbe LJA; Groothuis-Oudshoorn CGM; Poortmans PMP; Siesling S
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1485-1493. PubMed ID: 31020418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
